Table 2 Patients characteristics
Parameter | Fixed dose protocol (n = 50) | LBW protocol (n = 50) | p value |
|---|---|---|---|
Gender | |||
Male | 24 (48%) | 23 (46%) | 0.842 |
Female | 26 (52%) | 27 (54%) | |
Age, years | 63.76 ± 13.21 (38–92) | 67.80 ± 11.91 (42–89) | 0.111 |
Height, m | 1.68 ± 0.10 (1.53–1.98) | 1.65 ± 0.09 (1.48–1.83) | 0.311 |
Weight, kg | 73.70 ± 13.67 (45–103) | 74.08 ± 15.61 (50–120) | 0.897 |
BMI, kg/m2 | 25.98 ± 4.03 (17.58–36.21) | 27.05 ± 5.26 (16.98–44.08) | 0.256 |
LBW, kg | 53.02 ± 9.94 (36.44–76.46) | 51.73 ± 8.83 (37.90–71.78) | 0.649 |
Contrast media | |||
Dose, gI | 42.00 ± 0.00 (42.00–42.00) | 36.21 ± 6.18 (26.53–50.24) | < 0.001 |
Volume, mL | 120.00 ± 0.00 (120–120) | 103.47 ± 17.65 (76–144) | < 0.001 |
Primary cancer | |||
Gastrointestinal | 22 (44%) | 19 (38%) | 0.833 |
Hepatobiliary | 6 (12%) | 8 (16%) | |
Genitourinary | 11 (22%) | 12 (24%) | |
Prostate | 7 (14%) | 9 (18%) | |
Other | 4 (8%) | 2 (4%) |